Northside Capital Management’s Gilead Sciences GILD Stock Holding History

Northside Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,160	Closed	-$291K	–	95
2021 Q3	$291K	Hold	4,160	–	–	0.08%	71
2021 Q2	$286K	Sell	4,160 -90	-2%	-$6.01K	0.07%	73
2021 Q1	$275K	Sell	4,250 -325	-7%	-$21K	0.08%	71
2020 Q4	$267K	Sell	4,575 -2,162	-32%	-$130K	0.08%	71
2020 Q3	$426K	Hold	6,737	–	–	0.14%	55
2020 Q2	$518K	Hold	6,737	–	–	0.18%	61
2020 Q1	$504K	Sell	6,737 -140	-2%	-$9.67K	0.25%	45
2019 Q4	$447K	Sell	6,877 -735	-10%	-$47.9K	0.15%	60
2019 Q3	$482K	Buy	7,612 +77	+1%	+$5.03K	0.17%	54
2019 Q2	$509K	Buy	7,535 +530	+8%	+$34.9K	0.2%	42
2019 Q1	$455K	Hold	7,005	–	–	0.18%	47
2018 Q4	$438K	Buy	7,005 +218	+3%	+$15.2K	0.19%	44
2018 Q3	$524K	Hold	6,787	–	–	0.19%	42
2018 Q2	$481K	Hold	6,787	–	–	0.17%	48
2018 Q1	$512K	Hold	6,787	–	–	0.17%	47
2017 Q4	$486K	Hold	6,787	–	–	0.14%	50
2017 Q3	$550K	Hold	6,787	–	–	0.23%	35
2017 Q2	$480K	Hold	6,787	–	–	0.21%	39
2017 Q1	$461K	Hold	6,787	–	–	0.13%	94
2016 Q4	$486K	Hold	6,787	–	–	0.17%	40
2016 Q3	$537K	Hold	6,787	–	–	0.21%	37
2016 Q2	$566K	Hold	6,787	–	–	0.27%	35
2016 Q1	$623K	Buy	+6,787	New	+$612K	0.39%	28

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Northside Capital Management's GILD Position: Q4 2021 in Review

Northside Capital Management sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 4,160 shares — an estimated $291K sold.

Northside Capital Management first reported a position in GILD in Q1 2016 and held it in 23 quarters. The position peaked at $623K in Q1 2016. 1,681 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

Northside Capital Management reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
Northside Capital Management sold 4,160 Gilead Sciences shares in Q4 2021, an estimated $291K.
Northside Capital Management first reported a position in Gilead Sciences in Q1 2016 and held it in 23 quarters.
Northside Capital Management's Gilead Sciences position peaked at $623K in Q1 2016.
1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Northside Capital Management's 13F filing for Q4 2021, filed 24 Jan 2022.